🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

RecruitingNAAges 18 Years - anyAllZiekenhuis Oost-Limburg
NCT06308965 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA. The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria To be eligible to participate in this study, a subject must meet all criteria below; * Scheduled for THA by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten * Provide signed and dated informed consent * Males or females age \> 18 years Exclusion criteria A potential subject who meets any of the following criteria will be excluded from participation in this study: * Neurological problems with sensorial and/or motoric disturbances (Multiple Sclerosis, Parkinson's disease, hemiplegia, …) * Previous surgery of the ipsilateral hip * Ipsilateral neck of femur fracture * Previous contralateral THA * Significant hip deformity: Crowe type 3 and 4 dysplasia, Leg-Calvé-Perthes * Avascular necrosis of the femoral head * Participating in another study that may interfere with participation in this study
💊

What it tests

  • Vessel sparing technique
  • Vessel ligation technique
📍

Where

1 site
Ziekenhuis Oost-Limburg
Genk, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy